clodronic acid has been researched along with Osteoradionecrosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Abed, H; Banjar, A; Patel, V | 1 |
| Somay, E; Topkan, E; Yilmaz, B | 1 |
| Barthelemy, I; Biau, J; Delbet, C; Depeyre, A; Dissard, A; Gilain, L; Guillemin, F; Martin, F; Mirafzal, S; Mom, T; P Dang, N; Pereira, B; Puechmaille, M; Saroul, N | 1 |
| Patel, N; Patel, S; Patel, V; Sassoon, I | 1 |
| Biau, J; Clavère, P; Dutheil, F; Guillemin, F; Lapeyre, M; Pham-Dang, N; Saroul, N | 1 |
| Kolokythas, A; Rivero, JA; Shamji, O | 1 |
| Balibrea-Del-Castillo, JM; Bescós-Atín, C; Estrugo-Devesa, A; López-López, J; Martos-Fernández, M; Saez-Barba, M | 1 |
| Dhanda, J; Rennie, L; Shaw, R | 1 |
| Magremanne, M | 1 |
| Bulsara, MK; Bulsara, VM; Lewis, E | 1 |
| Benmoussa, N; Bidault, F; Dinnoo, A; Elmaalouf, M; Janot, F; Lassau, N; Moya-Plana, A; Ruffier, A | 1 |
| McCaul, JA | 1 |
| Babin, E; Blanchard, D; Delanian, S; Louis, MY; Robard, L | 1 |
| Ekanayake, K; Omer, O; Polyzois, I; Rice, N; Stassen, LF | 1 |
| Agrawal, SK; Fung, K; Glicksman, JT; Khalili, S; Parnes, LS | 1 |
| Costa, DA; Costa, TP; Guerreiro, FG; Joaquim, N; Moreira, AR; Netto, EC; Pinho, AC; Pratas, AC; Sargento, IG; Silva, IP; Ventura, I; Winckler, P | 1 |
| Chatel, C; Delanian, S; Depondt, J; Lefaix, JL; Porcher, R | 1 |
| Delanian, S; Depondt, J; Lefaix, JL | 1 |
| Delanian, S; Lefaix, JL | 1 |
7 review(s) available for clodronic acid and Osteoradionecrosis
| Article | Year |
|---|---|
Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review.
Topics: Clodronic Acid; Drug Therapy, Combination; Humans; Observational Studies as Topic; Osteoradionecrosis; Pentoxifylline; Randomized Controlled Trials as Topic; Retrospective Studies; Tocopherols; Vitamin E | 2023 |
[Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].
Topics: Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Radiotherapy Dosage; Risk Factors; Tocopherols | 2021 |
Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
Topics: Clodronic Acid; Drug Combinations; Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2017 |
Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
Topics: Clodronic Acid; Drug Combinations; Head and Neck Neoplasms; Humans; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2018 |
Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
Topics: Anti-Bacterial Agents; Antioxidants; Bone Density Conservation Agents; Chemoradiotherapy; Clodronic Acid; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Jaw Diseases; Orthognathic Surgical Procedures; Osteoradionecrosis; Pentoxifylline; Plastic Surgery Procedures; Radiation-Protective Agents; Tocopherols | 2014 |
The management of osteoradionecrosis of the jaws--a review.
Topics: Algorithms; Anti-Inflammatory Agents; Clodronic Acid; Fibrosis; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Jaw Diseases; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiotherapy; Tocopherols | 2015 |
New perspectives on the conservative management of osteoradionecrosis of the mandible: A literature review.
Topics: Antioxidants; Bone Density Conservation Agents; Clodronic Acid; Conservative Treatment; Drug Therapy, Combination; Humans; Hyperbaric Oxygenation; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2016 |
3 trial(s) available for clodronic acid and Osteoradionecrosis
| Article | Year |
|---|---|
Protocol for prospective randomised assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline+TOcopherol± CLOdronate for the management of early osteoradionecrosis of the mandible.
Topics: Adult; Bone Density Conservation Agents; Clinical Protocols; Clodronic Acid; Drug Combinations; Female; Humans; Hyperbaric Oxygenation; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Pilot Projects; Prospective Studies; Tocopherols | 2019 |
Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Ciprofloxacin; Clodronic Acid; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Prednisone; Prognosis; Tocopherols | 2011 |
Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial.
Topics: Adult; Aged; Antimetabolites; Antioxidants; Clodronic Acid; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiography; Radiotherapy; Tocopherols; Wound Healing | 2005 |
9 other study(ies) available for clodronic acid and Osteoradionecrosis
| Article | Year |
|---|---|
Comments on Dinnoo et al., 2021: ''18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality''.
Topics: Clodronic Acid; Fluorodeoxyglucose F18; Humans; Osteoradionecrosis; Positron Emission Tomography Computed Tomography | 2023 |
Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Clodronic Acid; Drug Combinations; Female; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Prospective Studies; Tocopherols; Treatment Outcome | 2020 |
The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
Topics: Clodronic Acid; Head and Neck Neoplasms; Humans; Jaw; Osteoradionecrosis; Pentoxifylline; Retrospective Studies; Tocopherols | 2021 |
Current trends in the medical management of osteoradionecrosis using triple therapy.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Chlorhexidine; Clodronic Acid; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Mandibular Diseases; Mouthwashes; Osteoradionecrosis; Pentoxifylline; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiation-Protective Agents; Severity of Illness Index; Tocopherols | 2018 |
Successful treatment of grade III osteoradionecrosis with mandibular fracture with pentoxifylline, tocopherol and clodronate.
Topics: Clodronic Acid; Female; Head and Neck Neoplasms; Humans; Mandibular Fractures; Middle Aged; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2018 |
Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol.
Topics: Clodronic Acid; Drug Combinations; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Osteoradionecrosis; Pentoxifylline; Tocopherols | 2020 |
Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Clodronic Acid; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Oral Ulcer; Osteoradionecrosis; Pentoxifylline; Radiography, Panoramic; Retrospective Studies; Tocopherols; Wound Healing | 2014 |
Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
Topics: Bone Density Conservation Agents; Clodronic Acid; Drug Combinations; Female; Humans; Middle Aged; Osteoradionecrosis; Parotid Neoplasms; Pentoxifylline; Temporal Bone; Tocopherols; Treatment Outcome | 2015 |
Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate.
Topics: Aged; Antimetabolites; Antioxidants; Breast Neoplasms; Clodronic Acid; Drug Therapy, Combination; Female; Humans; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiotherapy, Adjuvant; Tocopherols | 2002 |